Correspondence 0001193125-24-268973 from Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc.
Date: Dec. 2, 2024 · CIK: 0001367644 · Accession: 0001193125-24-268973
AI Filing Summary & Sentiment
File numbers found in text: 333-283150
Show Raw Text
CORRESP 1 filename1.htm CORRESP December 2, 2024 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Emergent BioSolutions Inc. Registration Statement on Form S-1 File No. 333-283150 Filed November 12, 2024 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Emergent BioSolutions Inc. hereby respectfully requests that the effective date for the above-referenced registration statement be accelerated to 4:00 p.m., Eastern Time, on December 4, 2024, or as soon as practicable thereafter. Should you have any questions or comments regarding the foregoing, please contact Matthew C. Franker or Julie M. Plyler of Covington & Burling LLP at (202) 662-5895 or (212) 841-1090, respectively. Respectfully, Emergent BioSolutions Inc. By: /s/ Jessica Perl Name: Jessica Perl Title: Senior Vice President, General Counsel and Corporate Secretary cc: Tamika Sheppard Matthew C. Franker Julie M. Plyler